Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
53 hedge funds and large institutions have $69.1M invested in Marrone Bio Innovations, Inc. in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
20% more funds holding
Funds holding: 44 → 53 (+9)
4% more capital invested
Capital invested by funds: $66.5M → $69.1M (+$2.66M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$129K |
| 2 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$89.7K |
| 3 |
SG Americas Securities
New York
|
+$74.2K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$49.3K |
| 5 |
SIM
Spark Investment Management
New York
|
+$46.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$252K |
| 2 |
Morgan Stanley
New York
|
-$150K |
| 3 |
State Street
Boston,
Massachusetts
|
-$148K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$59.5K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$51.7K |
MBII Hedge Fund Activity: Q1 2019 in Review
53 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2019, worth a combined $69.1M — up 4% from $66.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new MBII positions and 1 closed out — a net gain of 9 holders — while 16 added to existing stakes and 13 trimmed.
The largest buyer was Vanguard Group, adding an estimated $129K. The largest seller was BlackRock, cutting an estimated $252K.
- 53 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2019, up from 44 in Q4 2018.
- Funds reported $69.1M of Marrone Bio Innovations, Inc. stock for Q1 2019, up 4% quarter-over-quarter.
- 10 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2019 and 1 closed out, a net change of +9 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $129K added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2019 was BlackRock, an estimated $252K sold.
Based on aggregated 13F filings for Q1 2019.